Financhill
Back

Lucid Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
34

LCID
Lucid Group

Last Price:
2.60
Seasonality Move:
-10.85%
Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
40.76
Seasonality Move:
-0.9%
Sell
34
Lucid Group (LCID) is a Sell

Is Lucid Group a Buy, Sell or Hold?

  • The current Lucid Group [LCID] share price is $2.60. The Score for LCID is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • LCID is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LCID Stock Price Chart

What is Lucid Group's stock price today?

  • The Lucid Group share price today is $2.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LCID is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.50
    The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

LCID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 46.5 Sell
Chaikin Money Flow: -8406917 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.57 - 2.83) Sell
Bollinger Bands (100): (2.53 - 3.19) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 494801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.79 - 41.97) Buy
Bollinger Bands (100): (40.81 - 48.79) Sell

LCID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.55 Buy
20-day SMA: 2.67 Sell
50-day SMA: 2.68 Sell
200-day SMA: 3.62 Sell
8-day EMA: 2.57 Buy
20-day EMA: 2.63 Sell
50-day EMA: 2.72 Sell
200-day EMA: 3.93 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.2 Buy
20-day SMA: 40.42 Buy
50-day SMA: 41.53 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.89 Buy
20-day EMA: 40.39 Buy
50-day EMA: 41.79 Sell
200-day EMA: 43.35 Sell

Lucid Group Earnings Growth & LCID Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.24 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Lucid Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):